USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Scemblix improves MMR rates for Ph+ CML-CP in phase III trial

Novartis presented positive results from the pivotal phase III ASC4FIRST trial as a late-breaking abstract at the 2024 American Society of Clinical Oncology meeting.

May 31, 2024

Vol.50 No.22

In Brief

Matt Kalaycio named chair of board of directors at NCCN

Matt Kalaycio was named chair of the board of directors at the National Comprehensive Cancer Network. Christopher H. Lieu was elected as vice chair, succeeding Kalaycio in the position he has held since 2022.

April 12, 2024

Vol.50 No.15

In Brief

Christopher Hourigan named professor and director of Cancer Research Center at Virginia Tech

Christopher Hourigan, a senior investigator and chief of the Laboratory of Myeloid Malignancies at the National Institutes of Health, will join Virginia Tech as a professor with the institute and director of its Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C.

April 05, 2024

Vol.50 No.14

Clinical Roundup

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors.

April 05, 2024

Vol.50 No.14

In Brief

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

Clinical Roundup

Large USC study identifies genetic markers that may help explain link between red meat and colorectal cancer

A study led by USC Norris Comprehensive Cancer Center, part of the Keck School of Medicine of USC, analyzed data on red and processed meat intake from 29,842 people with colorectal cancer and 39,635 people without cancer.

March 22, 2024

Vol.50 No.12

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

YOU MAY BE INTERESTED IN

Scemblix improves MMR rates for Ph+ CML-CP in phase III trial

Matt Kalaycio named chair of board of directors at NCCN

Christopher Hourigan named professor and director of Cancer Research Center at Virginia Tech

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

Large USC study identifies genetic markers that may help explain link between red meat and colorectal cancer

Renew today!

Subscriber content

Login